- Home
- IKT vs DSP Comparison
IKT vs DSP Comparison
Compare IKT & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IKT | DSP |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.9M | 184.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IKT | DSP |
|---|---|---|
| Price | $1.54 | $11.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $4.00 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 411.5K | 224.8K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.49 |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $324,131,000.00 |
| Revenue This Year | N/A | $17.79 |
| Revenue Next Year | N/A | $17.72 |
| P/E Ratio | ★ N/A | $118.81 |
| Revenue Growth | N/A | ★ 22.97 |
| 52 Week Low | $1.33 | $8.11 |
| 52 Week High | $4.20 | $26.33 |
Technical Indicators
Market Signals| Indicator | IKT | DSP |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 64.12 |
| Support Level | $1.43 | $11.07 |
| Resistance Level | $1.57 | $12.48 |
| Average True Range (ATR) | 0.10 | 0.49 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 73.81 | 68.67 |
Price Performance
Historical ComparisonAbout IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.